Belvedere Trading’s Teladoc Health TDOC Stock Holding History

Belvedere Trading’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,500	Closed	-$155K	–	986
2025 Q1	$155K	Buy	+19,500	New	+$197K	﹤0.01%	382

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Belvedere Trading's TDOC Position: Q3 2025 in Review

Belvedere Trading sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 12,944 shares — an estimated $113K sold.

Belvedere Trading first reported a position in TDOC in Q2 2025 and held it in 1 quarter. The position peaked at $113K in Q2 2025. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

Belvedere Trading reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
Belvedere Trading sold 12,944 Teladoc Health shares in Q3 2025, an estimated $113K.
Belvedere Trading first reported a position in Teladoc Health in Q2 2025 and held it in 1 quarter.
Belvedere Trading's Teladoc Health position peaked at $113K in Q2 2025.
355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Belvedere Trading's 13F filing for Q3 2025, filed 27 Oct 2025.